Other News

Intact Vascular to Sponsor Post-Angioplasty Dissection Symposium at 2019 New Cardiovascular Horizons Conference

WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the schedule of key presentations to be featured during a lunch symposium at the 2019 New Cardiovascular Horizons (NCVH) Conference, May 29th through 31st at The Roosevelt New Orleans in New Orleans, Louisiana. Recently FDA-approved […]

Corindus to Showcase CorPath® GRX Robotic System at EuroPCR 2019

WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that it will showcase advanced robotic capabilities of the CorPath GRX System at EuroPCR 2019 in Paris, France from May 21-24, 2019. Corindus will use the annual meeting at EuroPCR […]

Neovasc Announces Closing of Private Placement of Convertible Debt and Common Shares for Gross Proceeds of US$11.5 Million

VANCOUVER, May 16, 2019 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ:NVCN)(TSX:NVCN) announced today that it has closed its previously announced private placement (the “Private Placement”) of (i) a 15% original issue discount convertible debenture (the “Debenture”) with a face value of US$11.5 million, for gross proceeds to the Company of US$9,775,000, and […]

Impella SmartAssist Platform Launches at SCAI, Designed to Further Improve Patient Outcomes

DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (NASDAQ:ABMD) announces today that the Impella CP with SmartAssist, which is designed to improve patient outcomes with advanced algorithms and simplified patient management, will be commercially available beginning at the 2019 Society for Cardiovascular Angiography & Interventions (SCAI) Scientific Sessions through a controlled launch process at select sites. The […]

TISSIUM Announces Publication in The Journal of Cardiovascular Surgery Detailing Preclinical and Clinical Evaluation of SETALIUMTM Vascular Sealant

PARIS–(BUSINESS WIRE)–TISSIUM, a privately-owned life science company developing fully synthetic, biomorphic programmable polymers, announced today the publication of its manuscript detailing preclinical and clinical evaluations of SETALIUMTM Vascular Sealant, the company’s first synthetic, biodegradable, on-demand, light-activated sealant. The results of these evaluations, published in The Journal of Cardiovascular Surgery on May 10th, 2019, […]

MediLynx Cardiac Monitoring Awarded Patent for Remote ECG Monitoring With Full Disclosure ECG Signal Transmission

PLANO, Texas, May 16, 2019 /PRNewswire/ — MediLynx Cardiac Monitoring LLC today announced the company has received a patent for its PocketECG full-disclosure ECG monitoring and transmission technology with patient symptomatic event reporting for remote cardiac monitoring. The patent covers use of the technology and methodology for arrhythmia monitoring and for remote or […]

Medtronic Launches Telescope(TM) Guide Extension Catheter to Support Complex Coronary Cases

DUBLIN – May 16, 2019 – Medtronic plc (NYSE:MDT), a global leader in percutaneous coronary intervention (PCI) innovation, today announced its entrance into the guide extension catheter market with the global launch of the Telescope(TM) Guide Extension Catheter, a newly designed catheter used to provide additional backup support and access to […]

Gore Receives FDA Approval for the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL

FLAGSTAFF, Ariz.–(BUSINESS WIRE)–W. L. Gore & Associates, Inc. (Gore) today announced that the U.S. Food and Drug Administration (FDA) has granted regulatory approval for commercial distribution for the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System, a unique Thoracic Endovascular Aortic Repair (TEVAR) solution combining new levels of control […]

Shockwave Appoints Keith D. Dawkins M.D. as Chief Medical Officer

SANTA CLARA, Calif., May 15, 2019 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that the Company has appointed Keith D. Dawkins, M.D. as Chief Medical Officer. “Given the challenges associated […]